Frank Karbe, Principal Fin'l & Accounting at Myovant Sciences Ltd. (MYOV), sold 300 shares at $24.00 ($7K) on 2021-01-28, disclosed to the SEC on 2021-02-01.
Scheduled sale ($7k) by Principal Fin'l & Accounting under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BTTX | BUY | 2023-04-12 | $402K | — | Filing → |
| BTTX | BUY | 2022-09-15 | $105K | — | Filing → |
| MYOV | SELL | 2021-07-09 | $70K | — | Filing → |